Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

Cited by (513)

Items 201–300 of 513

1. Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development
   Pascal S. Krenger, Magali Roques, Anne‐Cathrine S. Vogt, Alessandro Pardini, Dominik A. Rothen, Ina Baļķe, Sophie T. Schnider, Mona Omar Mohsen, Volker Theo Heussler, Andris Zeltiņš et al. · 2024 · npj Vaccines
2. Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants
   Wangqi Du, Peipei Jiang, Qingfeng Li, Wen He, Maolin Zheng, Jing Zhang, Yanru Guo, Jia Yang, Weixu Feng, Sisi Ye et al. · 2022 · Microbiology Spectrum
3. COVID-19 Vaccination in Kidney Transplant Candidates and Recipients
   Claudio Ponticelli, Mariarosaria Campise · 2022 · Vaccines
4. Durability of COVID-19 vaccine induced T-cell mediated immune responses measured using the QuantiFERON SARS-CoV-2 assay
   2022
5. Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry
   Bayram Farisoğulları, Saskia Lawson‐Tovey, Kimme Leanne Hyrich et al. · 2024 · Annals of the Rheumatic Diseases
6. Immune responses to Sinopharm/ BBIBP‐CorV in individuals in Sri Lanka
   Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, Achala Kamaladasa, Dinuka Guruge, Ayesha Wijesinghe, Banuri Gunasekera, Shyrar Tanussiya, Heshan Kuruppu, Thushali Ranasinghe et al. · 2022 · Immunology
7. Correlation between Baseline 25(OH) Vitamin D Levels and Both Humoral Immunity and Breakthrough Infection Post-COVID-19 Vaccination
   Rami Abu Fanne, Ghalib Lidawi, Emad Maraga, Mahmud Moed, Ariel Roguin, Simcha-Ron Meisel · 2022 · Vaccines
8. Evaluation of response to different COVID‐19 vaccines in vaccinated healthcare workers in a single center in Iran
   2022
9. Development and validation of a deep learning model to diagnose COVID‐19 using time‐series heart rate values before the onset of symptoms
   Heewon Chung, Hoon Ko, Hooseok Lee, Dong Keon Yon, Won Hee Lee, Tae‐Seong Kim, Kyung Won Kim, Jinseok Lee · 2023 · Journal of Medical Virology
10. Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination
    Laura Esparcia-Pinedo, Ayla Yarci-Carrión, Gloria Mateo-Jiménez, Noelia Ropero, Laura Gómez, A. Lancho, Patricia Almendro-Vázquez, Enrique Martín‐Gayo, Estela Paz‐Artal, Francisco Sánchez‐Madrid et al. · 2022 · Clinical Infectious Diseases
11. Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants
    Rashed Noor · 2022 · Viruses
12. A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination
    Fumi Sato-Kaneko, Shiyin Yao, Fitzgerald S. Lao, Yukiya Sako, Jasmine Jin, Nikunj M. Shukla, Howard Brinkerhoff Cottam, Michael David Chan, Masiel M. Belsuzarri, Dennis Anthony Carson et al. · 2022 · Vaccines
13. SARS-CoV-2 Infection in Fully Vaccinated Individuals of Old Age Strongly Boosts the Humoral Immune Response
    Lisa Müller, Marcel Andrée, Philipp Niklas Ostermann, Nathalie Jazmati, Greta Flüh, Johannes Fischer, Edwin Bölke, Eva Heger, Kanika Vanshylla, Florian Klein et al. · 2021 · Frontiers in Medicine
14. COVID‐19 post‐vaccination lymphadenopathy: A review of the use of fine needle aspiration cytology
    Alessandro Caputo, Alessia Caleo, Immacolata Cozzolino · 2023 · Cytopathology
15. A chimeric adenovirus‐vectored vaccine based on Beta spike and Delta RBD confers a broad‐spectrum neutralization against Omicron‐included SARS‐CoV‐2 variants
    Weiqi Hong, Lei Hong, Dandan Peng, Yuhe Huang, Cai He, H. J. Yang, Yanan Zhou, Jian Liu, Xiangyu Pan, Haiying Que et al. · 2024 · MedComm
16. Preventive Measures against Pandemics from the Beginning of Civilization to Nowadays—How Everything Has Remained the Same over the Millennia
    Laura Vitiello, Sara Ilari, Luigi Sansone, Manuel Belli, Mario Cristina, Federica Marcolongo, Carlo Tomino, Lucia Gatta, Vincenzo Mollace, Stefano Bonassi et al. · 2022 · Journal of Clinical Medicine
17. AttentionCovidNet: Efficient ECG-based diagnosis of COVID-19
    Wesley Chorney, Haifeng Wang, Lir‐Wan Fan · 2023 · Computers in Biology and Medicine
18. ELISA-R: an R-based method for robust ELISA data analysis
    2024
19. Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses
    Yajie Lin, Jiajie Zhu, Zongming Liu, Chaonan Li, Yikai Guo, Ying Wang, Keda Chen · 2022 · Frontiers in Immunology
20. Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity
    Ursino Pacheco-García, Jeanet Serafín‐López · 2023 · Vaccines
21. Knowledge, Attitude, and Acceptance of Sinopharm and AstraZeneca’s COVID-19 Vaccines among Egyptian Population: A Cross-Sectional Study
    Marian S. Boshra, Marwa O. Elgendy, Lamiaa N. Abdelaty, Mahmoud Tammam, Abdullah Salah Alanazi, Abdulaziz Ibrahim Alzarea, Saud Mohammad Alsahali, Rania M. Sarhan · 2022 · International Journal of Environmental Research and Public Health
22. COVID-19 Vaccine-Associated Pneumonitis in the Republic of Korea: A Nationwide Multicenter Survey
    Hongseok Yoo, Song Yee Kim, Moo Suk Park, Sung Hwan Jeong, Sung-Woo Park, Hong Lyeol Lee, Hyun-Kyung Lee, Sei‐Hoon Yang, Yangjin Jegal, Jung‐Wan Yoo et al. · 2023 · Journal of Korean Medical Science
23. COVID-19 Vaccine: Review of the Mechanism of Action of Different Types of Vaccine
    Li-Ann Wong, Christina Gertrude Yap, Nowrozy Kamar Jahan, Naganathan Pillai · 2022 · OALib
24. IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2
    Lorena O. Fernandes-Siqueira, Bruna G. Sousa, Carlos E. Cleto et al. · 2022 · Journal of Clinical Virology Plus
25. Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls
    Nussara Pakvisal, Panot Sainamthip, Nattaya Teeyapun, Sutima Luangdilok, Nassamon Wanlapakorn, Ritthideach Yorsaeng, Yong Poovorawan, Piyapoom Pakvisal, Thiti Susiriwatananont, Nicha Zungsontiporn et al. · 2022 · Human Vaccines & Immunotherapeutics
26. Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control
    Marie Mura, Fabrice Simon, Vincent Pommier de Santi, Frédéric Tangy, Jean‐Nicolas Tournier · 2022 · Vaccines
27. A quick scoping review of the first year of vaccination against the COVID-19 pandemic: Do we need more shots or time?
    Ayman Ahmed El-Menyar, Naushad Ahmad Khan, Ahammed Abdulla Mekkodathil, Sandro Baleotti Rizoli, Rafael J. Consunji, Eman Elmenyar, Sagar C. Galwankar, Hassan Ali Saoud Al-Thani · 2022 · Medicine
28. The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development
    Khalid Hajissa, Ali Mussa, Mohmed Isaqali Karobari, Muhammad Adamu Abbas, Ibrahim Khider Ibrahim, Ali A Assiry, Azhar Iqbal, Saad Alhumaid, Abbas Saleh Al Mutair, Ali Ahmed Rabaan et al. · 2022 · Vaccines
29. Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?
    2022
30. Modelling the impact of hybrid immunity on future COVID-19 epidemic waves
    Thao P. Le, Isobel R. Abell, Eamon J Conway, Patricia T. Campbell, Alexandra B. Hogan, Michael Lydeamore, Jodie McVernon, Ivo Müeller, Camelia R. Walker, Christopher M. Baker · 2024 · BMC Infectious Diseases
31. Immune response to COVID-19 vaccination in a population with and without a previous SARS-CoV-2 infection
    Mary Duro, C Almeida, Inês Duro · 2022 · Irish Journal of Medical Science (1971 -)
32. Emerging trends of research on mRNA vaccines: A co-citation analysis
    Juan Chen, Ting Zhang, Yan Zhen Lu, Xiaoyi Yang, Zhaolian Ouyang · 2022 · Human Vaccines & Immunotherapeutics
33. Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters
    Juan García-Bernalt Diego, Gagandeep Singh, Sonia Jangra, Kim Handrejk, Manon Laporte, Lauren A. Chang, Sara S. El Zahed, Lars Pache, Max W. Chang, Prajakta Warang et al. · 2024 · PLoS Pathogens
34. Serum peptidome profiles immune response of COVID-19 Vaccine administration
    Wenjia Zhang, Dandan Li, Bin Xu, Lanlan Xu, Qian Lyu, Xiangyi Liu, Zhijie Li, Jian Zhang, Wei Sun, Qingwei Ma et al. · 2022 · Frontiers in Immunology
35. A replication-competent smallpox vaccine LC16m8Δ-based COVID-19 vaccine
    Akihiko Sakamoto, Hiroaki Osawa, Hinata Hashimoto, Tetsushi Mizuno, Ammar Abdurrahman Hasyim, Yu-ichi Abe, Yuto Okahashi, Ryohei Ogawa, Mitsuhiro Iyori, Hisatoshi Shida et al. · 2022 · Emerging Microbes & Infections
36. Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
    Li Yang Hsu, Julia Hurraß, Annelene Kossow, Jan Klobucnik, Johannes Nießen, Gerhard A. Wiesmüller, Barbara Grüne, Christine Joisten · 2022 · Public Health
37. The Immunogenicity and Safety of Three Types of SARS-CoV-2 Vaccines in Adult Patients with Immune-Mediated Inflammatory Diseases: A Longitudinal Cohort Study
    Ni Tien, Yu-Chang Chang, Po‐Ku Chen, Hui‐Ju Lin, Shih‐Hsin Chang, Joung‐Liang Lan, Po‐Ren Hsueh, Ching‐Kun Chang, Der‐Yuan Chen · 2022 · Biomedicines
38. Short-Term Immune Response After Inactivated SARS-CoV-2 (CoronaVac®, Sinovac) And ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) Vaccinations in Thai Health Care Workers
    Watsamon Jantarabenjakul, Napaporn Chantasrisawad, Thanyawee Puthanakit, Supaporn Wacharapluesadee, Nattiya Hirankarn, Vichaya Ruenjaiman, Leilani Paitoonpong, Gompol Suwanpimolkul, Pattama Torvorapanit, Rakchanok Pradit et al. · 2021 · medRxiv
39. Immunoinformatics-Driven Strategies for Advancing Epitope-Based Vaccine Design for West Nile Virus
    Axl Laurens Lukas Windah, Trina Ekawati Tallei, Bashayer Mohammed Alshehail, Elly Juliana Suoth, Fatimawali Fatimawali, Yousef N. Alhashem, Muhammad Abdulrahman Halwani, Mouayd M. AlShakhal, Mohammed Mubarak Aljeldah, Mohammed Alissa et al. · 2023 · Journal of Pharmaceutical Sciences
40. Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
    Antoni Prenafeta, Gregori Bech-Sàbat, Alexandra Moros, Antonio Barreiro, Alex Fernández, Manuel Cañete, Mercè Roca, Luis González‐González, Carme Garriga, Joachim Confais et al. · 2023 · iScience
41. Immunization in pregnancy to protect pregnant people and their newborns against COVID-19
    Mahin Delara, Manish Sadarangani · 2022 · Expert Review of Vaccines
42. Impact of timing and combination of different BNT162b2 and ChAdOx1-S COVID-19 basic and booster vaccinations on humoral immunogenicity and reactogenicity in adults
    Simon Dedroogh, Sven Schmiedl, Petra Thürmann, Katharina Graf, Sebastian Appelbaum, Reinhard Koß, Christian Theis, Zewarudin Zia, Jürgen Tebbenjohanns, Serge Christian Thal et al. · 2023 · Scientific Reports
43. Understanding the effectiveness of the Comirnaty monovalent and bivalent vaccines during the Winter Coronavirus (COVID-19) Infection Study
    Thomas Ward, Robert Stephen Paton, Christopher E. Overton, Jonathon Mellor, Nurin Iwani Binti Abdul Aziz, André Charlett, Martyn Fyles · 2025 · Journal of Infection
44. Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort
    Liguo Zhu, Naiying Mao, Changhua Yi, Aidibai Simayi, Jialu Feng, Yi Feng, Min Yi He, Songning Ding, Yin Wang, Yan Wang et al. · 2022 · Emerging Microbes & Infections
45. Immune Cells Profiles In The Peripheral Blood Of Patients With Moderate To Severe COVID-19 And Healthy Subjects With and Without Vaccination With The Pfizer-BioNTech mRNA Vaccine
    Rajaa Al‐Attiyah, Hussain A. Safar, Lotfy Botras, Marina Botras, Fatma Al-Kandari, Wassim Chehadeh, Abu Salim Mustafa · 2022 · Frontiers in Immunology
46. BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the COVISHIELDTM vaccine in SARS-CoV-2 seronegative young Indian adults
    Srabanti Rakshit, Vasista Adiga, Asma Ahmed, Chaitra Parthiban, Nirutha Chetan Kumar, Sudarshan Shivalingaiah, Srishti Rao, George D′Souza, Pratibha Dwarkanath, Mary Dias et al. · 2022 · Research Square
47. In vitro high-content tissue models to address precision medicine challenges
    Samson Afewerki, Thiago Domingues Stocco, André D. R. Silva, André Sales Aguiar Furtado, Gustavo Fernandes de Sousa, Guillermo U. Ruiz‐Esparza, Thomas Jay Webster, Fernanda Roberta Marciano, Maria Strømme, Yu Shrike Zhang et al. · 2022 · Molecular Aspects of Medicine
48. Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients with COVID-19: Insights into New SARS-CoV-2 Variants, Vaccination Status, and Emerging Oral Antivirals
    Azita H Talasaz, P. Sadeghipour, Kasra Mehdizadeh, Niloofar Khoshnam-Rad, B. Bikdeli, G. Lip, J. Harenberg · 2022 · Thrombosis and Haemostasis
49. Retrospective Cohort Study of COVID-19 in Patients of the Brazilian Public Health System with SARS-CoV-2 Omicron Variant Infection
    T. Murari, Larissa Moraes dos Santos Fonseca, Hernane B. de B Pereira, A. Nascimento, Hugo Saba, F. Scorza, A. D. de Almeida, E. Maciel, J. Mendes, T. Rocha et al. · 2022 · Vaccines
50. The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study
    Thachanun Porntharukchareon, Wipada Chartisathian, Manassamon Navinpipat, Chayanee Samdaengpan, Kunsuda Cheirsilpa, Aimwipa Lueprasitsakul, Supanat Worawichawong, Viroj Muangsillapasart, Pratya Pumuthaivirat, Bothamai Dechates et al. · 2023 · Human Vaccines & Immunotherapeutics
51. Does COVID-19 vaccination increase the risk of interstitial lung disease at a population level?
    2024
52. Lowering maintenance immune suppression in elderly kidney transplant recipients; connecting the immunological and clinical dots
    Michiel G.H. Betjes, Annelies de Weerd · 2023 · Frontiers in Medicine
53. Depending on Epitope Profile of COVID-19 mRNA Vaccine Recipients: Are They More Efficient Against the Arising Viral Variants? An Opinion Article
    Nawal Abd El‐Baky, Amro Abd Al Fattah Amara · 2022 · Frontiers in Medicine
54. Cross‐neutralization of RBD mutant strains of SARS‐CoV‐2 by convalescent patient derived antibodies
    Yan Lou, Wenxiang Zhao, Haitao Wei, Min Gyeom Chu, Ruihua Chao, Hangping Yao, Junwei Su, Yanan Li, Xiulan Li, Yu Cao et al. · 2021 · Biotechnology Journal
55. COVID-19: State of the Vaccination
    Caroline Fenton, Yvette N. Lamb · 2021 · Drugs & Therapy Perspectives
56. Caveats of chimpanzee ChAdOx1 adenovirus-vectored vaccines to boost anti-SARS-CoV-2 protective immunity in mice
    Jacquelynne Brenda Cervantes‐Torres, Carlos Cabello-Gutiérrez, Dolores Adriana Ayón‐Núñez, Gloria Soldevila, Roxana Olguín‐Alor, Georgina Díaz, Gonzalo Acero, René Alvaro Segura‐Velázquez, Leonor Huerta, Isabel Gracia‐Mora et al. · 2024 · Applied Microbiology and Biotechnology
57. Comparable antigen-specific T cell responses in vaccinees with diverse humoral immune responses after the primary and booster BBIBP-CorV vaccination
    Dong Wei, Yingying Chen, Xiaoqi Yu, Yangdian Lai, Wenxin Xu, Ping Ji, Zhitao Yang, Erzhen Chen, Xinxin Zhang, Ying Wang · 2022 · Emerging Microbes & Infections
58. Cellular Responses to Membrane and Nucleocapsid Viral Proteins Are Also Boosted After SARS-CoV-2 Spike mRNA Vaccination in Individuals With Either Past Infection or Cross-Reactivity
    Alejandro Vallejo, Adrián Martín-Hondarza, Sandra Gómez, Héctor Velasco, Pilar Vizcarra, Johannes Häemmerle, José L. Casado · 2022 · Frontiers in Microbiology
59. The Evolution of Serological Assays during Two Years of the COVID-19 Pandemic: From an Easy-to-Use Screening Tool for Identifying Current Infections to Laboratory Algorithms for Discovering Immune Protection and Optimizing Vaccine Administration
    Eleonora Nicolai, Flaminia Tomassetti, Stefano Pignalosa, Serena Redi, Mariapaola Marino, Umberto Basile, Marco Ciotti · 2024 · COVID
60. Comparative effectiveness of allocation strategies of COVID-19 vaccines and antivirals against emerging SARS-CoV-2 variants of concern in East Asia and Pacific region
    2021
61. Evaluation of an RBD-nucleocapsid fusion protein as a booster candidate for COVID-19 vaccine
    Bruno Vinícius Santos Valiate, Júlia Teixeira de Castro, Tomas G. Marçal, Luis Adan Flores Andrade, Livia I. Oliveira, GABRIELA BARBI FREIRE MAIA, Lídia Faustino, Natália Satchiko Hojo-Souza, Marconi Augusto Aguiar dos Reis, Flávia Fonseca Bagno et al. · 2024 · iScience
62. The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
    Su-Yi Liew, Timothy I. M. Tree, Catherine H. Smith, Satveer K. Mahil · 2022 · Current Dermatology Reports
63. Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4
    2025
64. Human Superantibodies to 3CLpro Inhibit Replication of SARS-CoV-2 across Variants
    Kittirat Glab-ampai, Kanasap Kaewchim, Thanatsaran Saenlom, Watayagorn Thepsawat, Kodchakorn Mahasongkram, Nitat Sookrung, Wanpen Chaicumpa, Monrat Chulanetra · 2022 · International Journal of Molecular Sciences
65. Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka
    2021
66. COVID-19 vaccination produces exercise-responsive SARS-CoV-2 specific T-cells regardless of infection history
    Kyle A. Smith, Tiffany M. Zúñiga, Forrest L. Baker, Helena Batatinha, Charles R. Pedlar, Shane C. Burgess, Michael P. Gustafson, Emmanuel Katsanis, Richard J. Simpson · 2023 · Journal of sport and health science/Journal of Sport and Health Science
67. Vaccination Strategies: Mixing Paths Versus Matching Tracks
    Achilleas Livieratos, Charalambos A. Gogos, Ιάσων Θωμάς, Karolina Akinosoglou · 2025 · Vaccines
68. Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database
    2023
69. Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapies
    2022
70. SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?
    Karen Krueger, Natasha Halasa, Michael G. Ison · 2021 · American Journal of Kidney Diseases
71. Plasma EV-miRNAs as Potential Biomarkers of COVID-19 Vaccine Immune Response in Cancer Patients
    Beatriz Almeida, Tânia R. Dias, Pedro Cruz, Mário Sousa‐Pimenta, Ana Luísa Teixeira, Catarina Esteves Pereira, Bruno Costa‐Silva, Júlio Oliveira, Rui Medeiros, Francisca Dias · 2024 · Vaccines
72. Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
    Martina Borghi, Alessandra Gallinaro, Maria Franca Pirillo, Andrea Canitano, Zuleika Michelini, Maria Laura De Angelis, Serena Cecchetti, Antonella Tinari, Chiara Falce, Sabrina Mariotti et al. · 2023 · Frontiers in Immunology
73. Screening key protective antigens of largemouth bass virus and evaluation of their immunoprotective efficacy.
    2025
74. Comparison of self-reported symptoms in COVID-19 patients who had or had not previously received COVID-19 mRNA vaccination
    Megumi Hara, Takeki Furue, Mami Fukuoka, Kentaro Iwanaga, Eijo Matsuishi, Toru Miike, Yuichiro Sakamoto, Naoko Mukai, Yuki Kinugasa, Mutsumi Shigyo et al. · 2023 · Human Vaccines & Immunotherapeutics
75. Virus-Mimetic Extracellular-Vesicle Vaccine Boosts Systemic and Mucosal Immunity via Immune Recruitment
    Jingru Li, Haonan Xing, Fan Meng, Ting Liu, Xiaoxuan Hong, Xiaolu Han, Yuhan Dong, Meng Li, Zengming Wang, Shuang Zhang et al. · 2024 · ACS Nano
76. ZnO-Based Electrochemical Immunosensor to Assess Vaccine-Induced Antibody-Mediated Immunity against Wild-Type and Gamma SARS-CoV-2 Strains
    Freddy A. Nunez, Ana Cristina Honorato de Castro, Isabela Pazotti Daher, Edécio Cunha‐Neto, Jorge Elias Kalil, Silvia Beatriz Boscardin, Alexandre J. C. Lanfredi, Vivian Leite de Oliveira, Wendel A. Alves · 2023 · Biosensors
77. Differential Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Response in Inactivated Virus–Vaccinated, Convalescent, and Breakthrough-Infected Subjects
    Luisa Fernanda Duarte, Yaneisi Vázquez, Benjamín Diethelm‐Varela, Valentina Pavez, Roslye V. Berríos-Rojas, Constanza Méndez, Claudia A. Riedel, Jessica A. White, Alexis M. Kalergis, Susan M. Bueno et al. · 2023 · The Journal of Infectious Diseases
78. Comparison between viral vector and mRNA based COVID-19 vaccination in prevalence and severity of regional immune reactions, and 18F-FDG PET/CT features.
    Narjess Ayati, Scott Evans, Seyed Rasoul Zakavi · 2023 · PubMed
79. JN.1: ongoing considerations of the shifting landscape of SARS-CoV-2 variants.
    2024
80. Impact of glycosylation on a broad-spectrum vaccine against SARS-CoV-2
    Han-Yi Huang, Hsin-Yu Liao, Xiaorui Chen, Szu-Wen Wang, Cheng-Wei Cheng, Md. Shahed-Al-Mahmud, Ting-Hua Chen, Jennifer M. Lo, Yo-Min Liu, Yimin Wu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
81. The Volterra-Lyapunov matrix theory and nonstandard finite difference scheme to study a dynamical system
    2023
82. Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein
    Xiangxiang Tian, Yifan Zhang, Zhangyufan He · 2022 · Frontiers in Immunology
83. The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech)
    Jessica Andries, Wildriss Viranaïcken, Colette Cordonin, Charline Herrscher, Cynthia Planesse, Bénédicte Roquebert, Marie Lagrange-Xélot, Chaker El Kalamouni, Olivier Meilhac, Patrick Mavingui et al. · 2022 · Scientific Reports
84. Impact of inactivated COVID-19 vaccines on viral shedding in B.1.617.2 (Delta) variant-infected patients
    Zhiliang Hu, Yi Bing Yin, Kai Wang, Miaomiao Xu, Chengyuan Ding, Yan Song, Changhua Yi, Junwei Li, Yongxiang Yi, Zhihang Peng · 2022 · Science China Life Sciences
85. Trajectories of Seroprevalence and Neutralizing Activity of Antibodies against SARS-CoV-2 in Southern Switzerland between July 2020 and July 2021: An Ongoing, Prospective Population-Based Cohort Study
    Rebecca Amati, Giovanni Piumatti, Giovanni Franscella, Peter Buttaroni, Anne-Linda Camerini, Laurie Corna, Sara Levati, Marta Fadda, Maddalena Fiordelli, Anna Maria Annoni et al. · 2023 · International Journal of Environmental Research and Public Health
86. Safety and Humoral and Cellular Immunogenicity of the BNT162b2 SARS-CoV-2 Vaccine in Liver-Transplanted Adolescents Compared to Healthy Adolescents
    Palittiya Sintusek, Supranee Buranapraditkun, Siriporn Khunsri, Varattaya Saengchaisukhonkit, Preeyaporn Vichaiwattana, Donchida Srimuan, Thanunrat Thongmee, Yong Poovorawan · 2022 · Vaccines
87. Population-Based Analysis of the Immunoglobulin G Response to Different COVID-19 Vaccines in Brazil
    Nigella M. Paula, Marcelo Santos Conzentino, Ana Carolina Aparecida Gonçalves, Renata da Silva, Karin Viana Weissheimer, Carlos H. S. Kluge, Paulo H. S. A. Marins, Haxley S. C. Camargo, Lucas R. P. Farias, Thamyres P. Sant’Ana et al. · 2022 · Vaccines
88. CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID‐19 therapy
    Thiago Lazari Machado, Alanna Calheiros Santos, Tamiris Azamor, Andrea M. V. da Silva, Vanessa Pimenta Rocha, Luciana Neves Tubarão, Alexandre dos Santos da Silva, Daniela del Rosário Flores Rodrigues, Rodrigo Müller, Marcelo Alves Pinto et al. · 2022 · Journal of Medical Virology
89. Independent Protection and Influence of the Spike-Specific Antibody Response of SARS-CoV-2 Nucleocapsid Protein (N) in Whole-Virion Vaccines
    Huijie Yang, Ying Xie, Shuaiyao Lu, Yufang Sun, Kaiqin Wang, Shuyan Li, Junzhi Wang, Guoyang Liao, Changgui Li · 2023 · Vaccines
90. Immunogenicity and safety of different combinations involving a third booster dose of SARS-CoV-2 inactivated vaccine, inactivated quadrivalent influenza vaccine, and 23-valent pneumococcal polysaccharide vaccine in adults aged ≥60 years: a phase 4, randomized, open-label study
    Shuang Bai, Shanshan Zhou, Junnan Zhang, Weixin Chen, Min Lv, Jian Wang, Ao Zhang, Jiang Wu, Wei Zhao · 2024 · Frontiers in Immunology
91. Combatting future variants of SARS-CoV-2 using an in-silico peptide vaccine approach by targeting the spike protein
    Subhamoy Biswas, Sumanta Dey, Shreyans Chatterjee · 2022 · Medical Hypotheses
92. SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 and correlates of protection in the UK general population
    Jia Wei, Koen Bernardus Pouwels, Nicole E Stoesser, Philippa Clare Matthews, Ian D. Diamond, Ruth Studley, Emma D. Rourke, Duncan Cook, John I. Bell, John N Newton et al. · 2021 · medRxiv
93. COVID-19 Vaccines for Optimizing Immunity in the Upper Respiratory Tract
    Ranjan Ramasamy · 2023 · Viruses
94. Evaluation of protection and immunity induced by infectious bronchitis vaccines administered by oculonasal, spray or gel routes in commercial broiler chicks.
    2023
95. Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster Vaccination
    Katharina Grikscheit, Holger Felix Rabenau, Zahra Ghodratian, Marek Widera, Alexander Wilhelm, Tuna Toptan, Sebastian Hoehl, Emily Layer, Fabian Helfritz, Sandra Ciesek · 2022 · Vaccines
96. Gene therapy. The legacy of Wacław Szybalski
    Józef Dulak · 2021 · Acta Biochimica Polonica
97. Mucosal immunity against SARS-CoV-2 variants of concern including Omicron following vaccination
    2022
98. Role of vaccination and anti-SARS-CoV-2 antibodies in the clinical outcome of hospitalized COVID-19 patients
    Enrique Bernal, Eva García-Villalba, Eduardo Pons, María Rosario Vicente, Cristina Tomás, Alfredo Minguela, Maria Dolores Hernández, Gabriel Puche, Paula Carter, Mónica Martínez Martínez et al. · 2023 · Medicina Clínica (English Edition)
99. Economic evaluation of vaccination against COVID‐19: A systematic review
    Zeinab Dolatshahi, Shahin Nargesi, Fatemeh Mezginejad, Bagheri Faradonbeh Saeed · 2024 · Health Science Reports
100. Effect of the third dose of BNT162b2 vaccine in quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare workers
     Romero-Ibarguengoitia, Maria Elena, Rivera-Salinas, Diego, Hernández-Ruíz, Yodira Guadalupe, Armendariz-Vázquez, Ana Gabriela, González-Cantú, Arnulfo, Barco-Flores, Irene Antonieta, González-Facio, Rosalinda, Montelongo-Cruz, Laura Patricia, Del Rio-Parra, Gerardo Francisco, Garza-Herrera, Mauricio René et al. · 2021